These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28393)

  • 1. Bioavailability of griseofulvin from a novel capsule formulation.
    Fell JT; Calvert RT; Riley-Bentham P
    J Pharm Pharmacol; 1978 Aug; 30(8):479-82. PubMed ID: 28393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tamaki N; Kamimura H; Katougi Y; Omi Y
    J Pharm Sci; 1982 Oct; 71(10):1169-72. PubMed ID: 7143218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.
    Bates TR; Fung HL; Lee H; Tembo AV
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):233-43. PubMed ID: 1153870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution rate and bioavailability of griseofulvin from a ground mixture with microcrystalline cellulose.
    Yamamoto K; Nakano M; Arita T; Nakai Y
    J Pharmacokinet Biopharm; 1974 Dec; 2(6):487-93. PubMed ID: 4461779
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1982 Feb; 5(2):120-4. PubMed ID: 7097474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
    J Pharm Sci; 1982 Oct; 71(10):1165-9. PubMed ID: 7143217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1984 Sep; 7(9):630-40. PubMed ID: 6527208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
    J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption characteristics of solid dispersed and micronized griseofulvin in man.
    Chiou WL; Riegelman S
    J Pharm Sci; 1971 Sep; 60(9):1376-80. PubMed ID: 5567588
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000.
    Chiou WL; Riegelman S
    J Pharm Sci; 1970 Jul; 59(7):937-42. PubMed ID: 5428085
    [No Abstract]   [Full Text] [Related]  

  • 14. Griseofulvin---phenobarbital interaction: a formulation-dependent phenomenon.
    Jamali F; Axelson JE
    J Pharm Sci; 1978 Apr; 67(4):466-70. PubMed ID: 641749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability of ultramicrosize griseofulvin (Gris-PEG) tablets in man.
    Barrett WE; Bianchine JR
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):501-9. PubMed ID: 810310
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in rats.
    Bloedow DC; Hayton WL
    J Pharm Sci; 1976 Mar; 65(3):328-34. PubMed ID: 57233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bioavailability of griseofulvin PEG ultramicrosize (Gris-PEG) tablets in man under steady-state conditions.
    Barrett WE; Hanigan JJ
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):491-500. PubMed ID: 810309
    [No Abstract]   [Full Text] [Related]  

  • 19. Intestinal absorption of griseofulvin from a triolein digestion mixture in rats.
    Grisafe JA; Hayton WL
    J Pharm Sci; 1978 Jul; 67(7):895-9. PubMed ID: 660503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
    Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
    Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.